January 21, 2013 — Varian Medical Systems received regulatory clearance from the Indian Atomic Energy Regulatory Board for the use of its TrueBeam high-intensity mode for advanced radiosurgical treatments.

January 21, 2013 — 3Disc, a manufacturer of digital imaging solutions, debuted next-generation FireCR+M medical and FireCR+M veterinary readers at RSNA 2012.

According to an article in the January issue of the ACR Bulletin, the ACR recently donated a one-of-kind film of Marie Curie receiving the ACR Gold Medal in 1931 to the Curie Museum in Paris. Famous for the discovery of polonium and radium, Curie was recognized by the ACR for her significant contributions to the field of radiology.  

 

Molecular Breast Imaging (MBI), also known as Breast-Specific Gamma Imaging (BSGI), is a procedure that is able to detect breast cancers missed by mammography and ultrasound, particularly in women with dense breasts. The MBI procedure is now available in hundreds of breast centers nationwide and is commonly utilized as a tool along with mammography and ultrasound to help in the diagnosis of breast cancer. Although the radiation dose associated with this procedure is already low enough to be used in select cases, new research is being conducted to find ways to reduce the dose further so that MBI may be used in annual breast cancer screening for high-risk women with dense breast tissue. The latest results from this research were presented at the Chicago International Breast Course in October by Marcela Bohm-Velez, M.D., the principal investigator of an ongoing trial at Weinstein Imaging Associates in Pittsburgh, Pa.

 

VidiStar Cardiology PACS

GE Healthcare announced that it has filed a supplemental new drug application (sNDA) that will allow the company to manufacture Optison (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), within its own facility. Optison is a contrast agent that may improve the visualization of the left ventricular border — an area of the heart that is critical to see in order to assess and diagnose certain heart diseases. Upon approval, GE Healthcare will provide supply of Optison to the U.S. market from its manufacturing facility in Oslo, becoming the only contrast media manufacturer to supply its own stock for the United States.

Agfa HealthCare previewed version 2 of its Impax Business Intelligence solution to the U.S. market at the 98th annual meeting of the Radiological Society of North America in November 2012.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now